We use cookies to offer you the best experience on our site. You can find out more about the cookies we use or disable them in the Cookie settings
CATALOG PEPTIDES
Beta-Amyloid x-42
Pyro-Glu modified beta-Amyloid forms show higher toxicity
Sequential proteolytic cleavage of the Amyloid Precursor Protein (APP) by secretases (α, b, g) generates beta-Amyloid peptide fragments. Beta-Amyloid 1-42 forms is the major component of amyloid plaques in neurons of Alzheimer’s disease (AD) brains, has high aggregation/fibrillation properties and is neurotoxic.
N-terminally truncated beta-Amyloid 3-42 ad 11-42, both having a Glu as first residue, are subjected to pyro-glutamination. Pyroglutamate-modified (Pyr) beta-Amyloid 3-42 and 11-42 have been described as major compounds in the senile AD plaques. Pyro-Glu modified beta-Amyloid forms are more resistant to degradation, show higher toxicity and have increased aggregation propensity compared to the non-modified beta-Amyloid equivalent.